24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Quris
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
07:29
MSC denies interest in acquiring ZIM
21:50
Full list of Israeli startup M&As in 2025
21:48
Zendesk acquires AI search startup Unleash for tens of millions
21:03
As Intel stumbles, Nvidia emerges as Israel’s anchor tech employer
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
5
Zendesk acquires AI search startup Unleash for tens of millions
More news
Quris
7 stories about Quris
Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles
04.01.24
|
CTech
Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.
Pharma giant Merck expands collaboration with Quris-AI
28.09.23
|
Meir Orbach
This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches
SoftBank leads $9 million investment in AI pharma startup Quris
20.12.22
|
Meir Orbach
The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials
CTech’s Book Review: Breaking down the barriers to set you free
13.07.22
|
Isaac Bentwich
Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer
Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction
09.02.22
|
Meir Orbach
The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant
Quris closes record $28 million Seed funding for AI drug development platform
11.01.22
|
Meir Orbach
The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing
Quris raises $9 million in Seed for its clinician prediction AI platform
21.10.21
|
James Spiro
The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.